Atlas Trials

A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

Clinical trial NCT04250506 · COMPLETED

Trial details

NCT number
NCT04250506
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2020-02-28
Primary completion
2020-07-22
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.